Sanofi Net Debt from 2010 to 2024

SNY Stock

USD 47.98 0.20 0.42%

Sanofi ADR Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt will likely drop to about 7.6 B in 2024. Net Debt is the total debt of Sanofi ADR minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2002-06-30

Previous Quarter

8.7 B

Current Value

17 B

Quarterly Volatility

4.8 B

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Sanofi ADR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sanofi ADR's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 B, Interest Expense of 607 M or Selling General Administrative of 11.2 B, as well as many indicators such as Price To Sales Ratio of 1.17, Dividend Yield of 0.0823 or PTB Ratio of 0.73. Sanofi financial statements analysis is a perfect complement when working with Sanofi ADR Valuation or Volatility modules.

Check out the analysis of Sanofi ADR Correlation against competitors.

For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Latest Sanofi ADR's Net Debt Growth Pattern

Below is the plot of the Net Debt of Sanofi ADR over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Sanofi ADR's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sanofi ADR's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Sanofi Net Debt Regression Statistics

	Arithmetic Mean	9,104,900,540
	Geometric Mean	7,250,225,031
	Coefficient Of Variation	46.90
	Mean Deviation	3,025,946,234
	Median	8,306,000,000
	Standard Deviation	4,270,337,926
	Sample Variance	18235786T
	Range	17.5B
	R-Value	0.38
	Mean Square Error	16806880.6T
	R-Squared	0.14
	Significance	0.16
	Slope	362,587,703
	Total Sum of Squares	255301004.1T

Sanofi Net Debt History

	2024	7.6 B
	2023	9.7 B
	2022	8.5 B
	2021	12.3 B
	2020	9.8 B
	2019	16.5 B
	2018	17.7 B

Other Fundumenentals of Sanofi ADR

Net Debt To E B I T D A

Sanofi ADR Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Retained Earnings	Long Term Debt	Property Plant Equipment	Treasury Stock	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.66	0.84	0.85	1.0	-0.61	0.98	0.9	0.6	0.79	0.84	0.15	0.02	0.68	0.56	0.01	0.48	0.32	-0.52	-0.02	0.57	0.55	0.43	-0.19	-0.02
Total Stockholder Equity	0.99		0.56	0.84	0.84	0.99	-0.6	0.95	0.9	0.58	0.78	0.84	0.1	0.02	0.63	0.59	-0.02	0.5	0.33	-0.5	0.08	0.52	0.5	0.43	-0.18	-0.01
Net Debt	0.66	0.56		0.56	0.6	0.66	-0.32	0.77	0.47	0.52	0.7	0.48	0.25	-0.11	0.64	0.25	0.25	0.35	0.16	-0.33	-0.65	0.61	0.54	0.38	-0.41	-0.05
Accounts Payable	0.84	0.84	0.56		0.57	0.84	-0.26	0.8	0.77	0.4	0.59	0.46	-0.18	-0.08	0.41	0.28	-0.05	0.69	0.31	-0.65	-0.02	0.75	0.69	0.66	-0.48	0.04
Net Receivables	0.85	0.84	0.6	0.57		0.85	-0.82	0.85	0.7	0.63	0.74	0.89	0.52	0.05	0.68	0.65	-0.03	0.03	0.22	-0.25	-0.08	0.21	0.21	0.09	-0.12	-0.12
Good Will	1.0	0.99	0.66	0.84	0.85		-0.6	0.98	0.9	0.58	0.79	0.83	0.16	0.01	0.7	0.57	-0.03	0.48	0.34	-0.55	-0.04	0.56	0.53	0.42	-0.2	-0.03
Short Term Investments	-0.61	-0.6	-0.32	-0.26	-0.82	-0.6		-0.59	-0.46	-0.29	-0.46	-0.87	-0.72	-0.19	-0.57	-0.65	0.16	0.29	0.18	0.2	0.02	0.09	0.03	0.19	0.15	-0.02
Total Liab	0.98	0.95	0.77	0.8	0.85	0.98	-0.59		0.89	0.6	0.79	0.81	0.21	0.01	0.72	0.51	0.04	0.44	0.31	-0.54	-0.16	0.62	0.59	0.41	-0.2	-0.04
Total Current Assets	0.9	0.9	0.47	0.77	0.7	0.9	-0.46	0.89		0.51	0.52	0.7	0.06	0.17	0.54	0.36	-0.01	0.43	0.44	-0.64	0.16	0.66	0.68	0.39	0.02	-0.04
Short Term Debt	0.6	0.58	0.52	0.4	0.63	0.58	-0.29	0.6	0.51		0.63	0.55	0.07	0.13	0.25	0.27	0.35	0.23	0.25	0.1	-0.09	0.35	0.34	0.35	-0.09	0.07
Intangible Assets	0.79	0.78	0.7	0.59	0.74	0.79	-0.46	0.79	0.52	0.63		0.73	0.04	-0.21	0.56	0.53	0.16	0.49	0.2	-0.13	-0.22	0.35	0.27	0.47	-0.24	0.15
Common Stock	0.84	0.84	0.48	0.46	0.89	0.83	-0.87	0.81	0.7	0.55	0.73		0.43	0.1	0.69	0.74	-0.01	0.08	0.08	-0.29	0.03	0.16	0.18	0.12	-0.06	0.13
Current Deferred Revenue	0.15	0.1	0.25	-0.18	0.52	0.16	-0.72	0.21	0.06	0.07	0.04	0.43		0.26	0.39	0.32	-0.23	-0.71	-0.13	0.1	-0.23	-0.37	-0.3	-0.69	0.05	-0.42
Retained Earnings	0.02	0.02	-0.11	-0.08	0.05	0.01	-0.19	0.01	0.17	0.13	-0.21	0.1	0.26		-0.13	-0.11	0.07	-0.18	0.14	-0.08	0.41	0.04	0.22	-0.24	0.12	-0.11
Long Term Debt	0.68	0.63	0.64	0.41	0.68	0.7	-0.57	0.72	0.54	0.25	0.56	0.69	0.39	-0.13		0.77	0.07	0.16	0.36	-0.5	-0.34	0.24	0.2	0.09	-0.02	-0.13
Property Plant Equipment	0.56	0.59	0.25	0.28	0.65	0.57	-0.65	0.51	0.36	0.27	0.53	0.74	0.32	-0.11	0.77		0.13	0.06	0.16	-0.14	0.1	-0.13	-0.16	-0.04	-0.01	-0.06
Treasury Stock	0.01	-0.02	0.25	-0.05	-0.03	-0.03	0.16	0.04	-0.01	0.35	0.16	-0.01	-0.23	0.07	0.07	0.13		0.26	0.0	0.24	0.0	0.31	0.32	0.24	-0.12	0.11
Deferred Long Term Liab	0.48	0.5	0.35	0.69	0.03	0.48	0.29	0.44	0.43	0.23	0.49	0.08	-0.71	-0.18	0.16	0.06	0.26		0.34	-0.42	0.02	0.73	0.63	0.84	-0.3	0.23
Long Term Investments	0.32	0.33	0.16	0.31	0.22	0.34	0.18	0.31	0.44	0.25	0.2	0.08	-0.13	0.14	0.36	0.16	0.0	0.34		-0.31	0.16	0.25	0.24	0.12	0.4	-0.37
Short Long Term Debt	-0.52	-0.5	-0.33	-0.65	-0.25	-0.55	0.2	-0.54	-0.64	0.1	-0.13	-0.29	0.1	-0.08	-0.5	-0.14	0.24	-0.42	-0.31		0.11	-0.64	-0.66	-0.47	0.25	-0.22
Net Tangible Assets	-0.02	0.08	-0.65	-0.02	-0.08	-0.04	0.02	-0.16	0.16	-0.09	-0.22	0.03	-0.23	0.41	-0.34	0.1	0.0	0.02	0.16	0.11		-0.21	-0.1	-0.16	0.4	-0.09
Long Term Debt Total	0.57	0.52	0.61	0.75	0.21	0.56	0.09	0.62	0.66	0.35	0.35	0.16	-0.37	0.04	0.24	-0.13	0.31	0.73	0.25	-0.64	-0.21		0.98	0.76	-0.39	0.18
Capital Surpluse	0.55	0.5	0.54	0.69	0.21	0.53	0.03	0.59	0.68	0.34	0.27	0.18	-0.3	0.22	0.2	-0.16	0.32	0.63	0.24	-0.66	-0.1	0.98		0.68	-0.35	0.2
Net Invested Capital	0.43	0.43	0.38	0.66	0.09	0.42	0.19	0.41	0.39	0.35	0.47	0.12	-0.69	-0.24	0.09	-0.04	0.24	0.84	0.12	-0.47	-0.16	0.76	0.68		-0.5	0.61
Net Working Capital	-0.19	-0.18	-0.41	-0.48	-0.12	-0.2	0.15	-0.2	0.02	-0.09	-0.24	-0.06	0.05	0.12	-0.02	-0.01	-0.12	-0.3	0.4	0.25	0.4	-0.39	-0.35	-0.5		-0.38
Capital Stock	-0.02	-0.01	-0.05	0.04	-0.12	-0.03	-0.02	-0.04	-0.04	0.07	0.15	0.13	-0.42	-0.11	-0.13	-0.06	0.11	0.23	-0.37	-0.22	-0.09	0.18	0.2	0.61	-0.38

Click cells to compare fundamentals

About Sanofi ADR Financial Statements

Sanofi ADR investors use historical fundamental indicators, such as Sanofi ADR's Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Sanofi ADR. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	9.7 B	7.6 B
Net Debt To EBITDA	0.77	0.54

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sanofi Net Debt from 2010 to 2024

Latest Sanofi ADR's Net Debt Growth Pattern

Sanofi Net Debt Regression Statistics

Sanofi Net Debt History

Other Fundumenentals of Sanofi ADR

Sanofi ADR Net Debt component correlations

About Sanofi ADR Financial Statements

Also Currently Popular

Additional Tools for Sanofi Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY